Clinical Trial Update: Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating buprenorphine for treating Neonatal Abstinence Syndrome in infants with in utero exposure to benzodiazepines; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Neonatal Abstinence Syndrome | Phase 1 | Status: COMPLETED